|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.710 USD | -4.13% |
|
-10.60% | +8.80% |
Company Valuation: LifeMD, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 118.4 | 61.01 | 325 | 214.4 | 164.1 | 179.4 | - | - |
| Change | - | -48.47% | 432.67% | -34.03% | -23.44% | 9.31% | - | - |
| Enterprise Value (EV) | 77.74 | 61.01 | 325 | 214.4 | 164.1 | 179.4 | 179.4 | 179.4 |
| Change | - | -21.52% | 432.67% | -34.03% | -23.44% | 9.31% | 0% | 0% |
| P/E | -1.69x | -1.24x | -11.8x | -9.34x | -19.5x | -13.6x | 49.9x | 12x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.2x | 0.4x | 0.3x | -0.2x | -0x | 0x |
| Capitalization / Revenue | 1.27x | 0.51x | 2.13x | 1.01x | 0.85x | 0.81x | 0.69x | 0.59x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.81x | 0.69x | 0.59x |
| EV / EBITDA | -0x | -0x | 0x | 0x | 0x | 13.6x | 5.82x | 3.57x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -18.7x | 23.6x | 7.58x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.29 | -1.57 | -0.7 | -0.53 | -0.1753 | -0.2729 | 0.0743 | 0.31 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 92.88 | 119 | 152.5 | 212.5 | 194.1 | 222 | 260.9 | 302.7 |
| EBITDA 1 | -38.28 | -14.66 | 11.98 | 14.38 | 15.25 | 13.22 | 30.8 | 50.21 |
| EBIT 1 | -54.3 | -43.45 | -14.49 | -16.14 | -7.67 | -9.572 | 7.616 | 23.67 |
| Net income 1 | -61.77 | -48.64 | -23.7 | -21.99 | -7.913 | -13.11 | 3.574 | 15.8 |
| Net Debt | -40.66 | - | - | - | - | - | - | - |
| Reference price 2 | 3.870 | 1.940 | 8.290 | 4.950 | 3.410 | 3.710 | 3.710 | 3.710 |
| Nbr of stocks (in thousands) | 30,593 | 31,450 | 39,203 | 43,312 | 48,136 | 48,363 | - | - |
| Announcement Date | 3/7/22 | 3/22/23 | 3/11/24 | 3/10/25 | 3/9/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -13.6x | - | - | - | 179M | ||
| 29.12x | 6.32x | 14x | -.--% | 30.25B | ||
| 73.66x | 63x | 78.47x | 0.5% | 11.68B | ||
| 78.1x | 11.5x | 49.92x | 0.75% | 5.28B | ||
| -30.28x | 8.47x | -45.86x | - | 2.08B | ||
| 52.56x | - | - | -.--% | 1.86B | ||
| -5.86x | 57.8x | -5.85x | - | 1.72B | ||
| -109.61x | - | - | - | 1.03B | ||
| 5.99x | - | - | - | 865M | ||
| 105.33x | - | - | 1.27% | 723M | ||
| Average | 18.54x | 29.42x | 18.14x | 0.5% | 5.57B | |
| Weighted average by Cap. | 38.52x | 21.65x | 29.37x | 0.21% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- LFMD Stock
- Valuation LifeMD, Inc.
Select your edition
All financial news and data tailored to specific country editions
















